126 related articles for article (PubMed ID: 11519702)
1. An evaluation of bone induction delivery materials in conjunction with root-form implant placement.
Boyne PJ; Shabahang S
Int J Periodontics Restorative Dent; 2001 Aug; 21(4):333-43. PubMed ID: 11519702
[TBL] [Abstract][Full Text] [Related]
2. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
[TBL] [Abstract][Full Text] [Related]
3. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates.
Hanisch O; Tatakis DN; Rohrer MD; Wöhrle PS; Wozney JM; Wikesjö UM
Int J Oral Maxillofac Implants; 1997; 12(6):785-92. PubMed ID: 9425759
[TBL] [Abstract][Full Text] [Related]
4. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
5. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins for periodontal and alveolar indications; biological observations - clinical implications.
Wikesjö UM; Qahash M; Huang YH; Xiropaidis A; Polimeni G; Susin C
Orthod Craniofac Res; 2009 Aug; 12(3):263-70. PubMed ID: 19627529
[TBL] [Abstract][Full Text] [Related]
7. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
[TBL] [Abstract][Full Text] [Related]
8. Analysis of performance of root-form endosseous implants placed in the maxillary sinus.
Boyne PJ
J Long Term Eff Med Implants; 1993; 3(2):143-59. PubMed ID: 10146541
[TBL] [Abstract][Full Text] [Related]
9. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
Boyne PJ
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
[TBL] [Abstract][Full Text] [Related]
10. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: a pilot study in rats.
Matin K; Senpuku H; Hanada N; Ozawa H; Ejiri S
Int J Oral Maxillofac Implants; 2003; 18(2):211-7. PubMed ID: 12705298
[TBL] [Abstract][Full Text] [Related]
11. The influence of a biomaterial on the closure of a marginal hard tissue defect adjacent to implants. An experimental study in the dog.
Botticelli D; Berglundh T; Lindhe J
Clin Oral Implants Res; 2004 Jun; 15(3):285-92. PubMed ID: 15142090
[TBL] [Abstract][Full Text] [Related]
12. Oral implants placed in bone defects treated with Bio-Oss, Ostim-Paste or PerioGlas: an experimental study in the rabbit tibiae.
Carmagnola D; Abati S; Celestino S; Chiapasco M; Bosshardt D; Lang NP
Clin Oral Implants Res; 2008 Dec; 19(12):1246-53. PubMed ID: 19040439
[TBL] [Abstract][Full Text] [Related]
13. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
Ramazanoglu M; Lutz R; Ergun C; von Wilmowsky C; Nkenke E; Schlegel KA
Clin Oral Implants Res; 2011 Dec; 22(12):1433-9. PubMed ID: 21418332
[TBL] [Abstract][Full Text] [Related]
14. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
[TBL] [Abstract][Full Text] [Related]
15. Sinus floor elevation using a bovine bone mineral (Bio-Oss) with or without the concomitant use of a bilayered collagen barrier (Bio-Gide): a clinical report of immediate and delayed implant placement.
Tawil G; Mawla M
Int J Oral Maxillofac Implants; 2001; 16(5):713-21. PubMed ID: 11669254
[TBL] [Abstract][Full Text] [Related]
16. Histologic findings in sinus augmentation with autogenous bone chips versus a bovine bone substitute.
Schlegel KA; Fichtner G; Schultze-Mosgau S; Wiltfang J
Int J Oral Maxillofac Implants; 2003; 18(1):53-8. PubMed ID: 12608669
[TBL] [Abstract][Full Text] [Related]
17. Surface-etching enhances titanium implant osseointegration in newly formed (rhBMP-2-induced) and native bone.
Qahash M; Hardwick WR; Rohrer MD; Wozney JM; Wikesjö UM
Int J Oral Maxillofac Implants; 2007; 22(3):472-7. PubMed ID: 17622015
[TBL] [Abstract][Full Text] [Related]
18. Osseointegration of oxidized and turned implants in circumferential bone defects with and without adjunctive therapies: an experimental study on BMP-2 and autogenous bone graft in the dog mandible.
Salata LA; Burgos PM; Rasmusson L; Novaes AB; Papalexiou V; Dahlin C; Sennerby L
Int J Oral Maxillofac Surg; 2007 Jan; 36(1):62-71. PubMed ID: 17027235
[TBL] [Abstract][Full Text] [Related]
19. Marginal bone stability using 3 different flap approaches for alveolar split expansion for dental implants: a 1-year clinical study.
Jensen OT; Cullum DR; Baer D
J Oral Maxillofac Surg; 2009 Sep; 67(9):1921-30. PubMed ID: 19686930
[TBL] [Abstract][Full Text] [Related]
20. Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2.
Sorensen RG; Wikesjö UM; Kinoshita A; Wozney JM
J Clin Periodontol; 2004 Sep; 31(9):796-804. PubMed ID: 15312104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
